Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Methods and Interventions - 1st Edition - ISBN: 9780444637161, 9780444637406

Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Methods and Interventions, Volume 224

1st Edition

Serial Volume Editors: Hamed Ekhtiari Martin Paulus
eBook ISBN: 9780444637406
Hardcover ISBN: 9780444637161
Imprint: Elsevier
Published Date: 19th January 2016
Page Count: 488
Tax/VAT will be calculated at check-out Price includes VAT (GST)
30% off
30% off
30% off
30% off
30% off
20% off
20% off
30% off
30% off
30% off
30% off
30% off
20% off
20% off
25% off
25% off
25% off
25% off
25% off
20% off
20% off
206.00
144.20
144.20
144.20
144.20
144.20
164.80
164.80
175.00
122.50
122.50
122.50
122.50
122.50
140.00
140.00
288.00
216.00
216.00
216.00
216.00
216.00
230.40
230.40
Unavailable
Price includes VAT (GST)
× DRM-Free

Easy - Download and start reading immediately. There’s no activation process to access eBooks; all eBooks are fully searchable, and enabled for copying, pasting, and printing.

Flexible - Read on multiple operating systems and devices. Easily read eBooks on smart phones, computers, or any eBook readers, including Kindle.

Open - Buy once, receive and download all available eBook formats, including PDF, EPUB, and Mobi (for Kindle).

Institutional Access

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

  • Preface: Neuroscience for Addiction Medicine: From Prevention to Rehabilitation
  • Part I: Neuroscience Methods for Addiction Medicine
    • Chapter 1: Animal models for addiction medicine: From vulnerable phenotypes to addicted individuals
      • Abstract
      • 1 Introduction
      • 2 Types of Animal Models
      • 3 Conclusions and Future Directions
      • Acknowledgments
    • Chapter 2: Animal models of drug relapse and craving: From drug priming-induced reinstatement to incubation of craving after voluntary abstinence
      • Abstract
      • 1 Introduction
      • 2 Extinction-based Relapse Models
      • 3 Abstinence-Based Relapse Models
      • 4 Conclusions
      • Acknowledgments
    • Chapter 3: Computational modeling for addiction medicine: From cognitive models to clinical applications
      • Abstract
      • 1 IGT and SGT decision-making Tasks
      • 2 The EVL and PVL Models
      • 3 Applications of the EVL and PVL Models to Clinical Populations Including Addiction
      • 4 Conclusion and Future Directions
      • Acknowledgments
    • Chapter 4: Electrophysiology for addiction medicine: From methodology to conceptualization of reward deficits
      • Abstract
      • 1 Gearing Up: Employing Electrophysiology to Study Reward in Addiction
      • 2 What Terrain Have We Covered in the Past Decade?
      • 3 Roadmap for Our Journey
      • 4 Our Tools: Electrophysiological Markers of Reward
      • 5 Comparing and Contrasting Types of Addiction
      • 6 Promising Avenues Ahead
    • Chapter 5: Neurocognitive rehabilitation for addiction medicine: From neurophysiological markers to cognitive rehabilitation and relapse prevention
      • Abstract
      • 1 Introduction
      • 2 A Possible Role for ERPs
      • 3 Preliminary Evidence from Alcohol Abuse Studies
      • 4 Converging Evidence from Other Addictive States
      • 5 Conclusion and Future Directions
      • Acknowledgments
    • Chapter 6: Structural imaging for addiction medicine: From neurostructure to neuroplasticity
      • Abstract
      • 1 Introduction
      • 2 Marijuana
      • 3 Adolescence (average Sample Age ≤ 21)
      • 4 Adulthood (average Sample Age ≥ 22, on Average)
      • 5 Stimulants
      • 6 Prenatal Exposure
      • 7 Exposure in Adolescence and Adulthood
      • 8 Opiates
      • 9 Quantitative Morphometry
      • 10 Diffusion Tensor Imaging
      • 11 Treatment Implications
      • 12 Conclusions and Future Directions
    • Chapter 7: Functional neuroimaging for addiction medicine: From mechanisms to practical considerations
      • Abstract
      • 1 Introduction
      • 2 Main Cognitive Targets in fMRI for Addiction Medicine
      • 3 Resting-State fMRI for Addiction Medicine
      • 4 fMRI Studies in Addiction Populations
      • 5 Possible Applications of fMRI for Addiction Medicine
      • 6 Major Challenges to fMRI for Addiction Medicine
      • 7 Conclusion and Future Directions
      • Acknowledgments
    • Chapter 8: Resting state functional connectivity analysis for addiction medicine: From individual loci to complex networks
      • Abstract
      • 1 Introduction
      • 2 Conclusions and Future Directions
      • Acknowledgments
    • Chapter 9: PET imaging for addiction medicine: From neural mechanisms to clinical considerations
      • Abstract
      • 1 Introduction
      • 2 PET Technologies to Study the Neurobiological Mechanisms Underlying Addiction
      • 3 PET Studies on Dopaminergic Neurotransmission in Addiction
      • 4 PET Studies in Addiction Beyond DA
      • 5 Future Directions
      • 6 PET, a Diagnostic Instrument?
      • 7 Conclusion and Future Directions
      • Acknowledgments
    • Chapter 10: Genetic imaging consortium for addiction medicine: From neuroimaging to genes
      • Abstract
      • 1 Introduction
      • 2 Genetic Basis of Addiction
      • 3 Enhancing Neuroimaging Genetics Through Meta-analysis
      • 4 ENIGMA Addiction Working Group
      • 5 Summary and Future Directions
      • Acknowledgments
  • Part II: Neuroscience for Interventions in Addiction Medicine
    • Chapter 11: Human pharmacology for addiction medicine: From evidence to clinical recommendations
      • Abstract
      • 1 Introduction
      • 2 Alcohol Use Disorders
      • 3 Nicotine
      • 4 Opioid Use Disorders
      • 5 Cocaine and Amphetamines
      • 6 Cannabis
      • 7 Benzodiazepines
      • 8 Gamma-Hydroxybutyrate
      • 9 Conclusion and Future Directions
      • Acknowledgments
    • Chapter 12: Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics
      • Abstract
      • 1 Introduction
      • 2 Peroxisome Proliferating Activator Receptors
      • 3 cAMP Response Element-binding Protein and the Inhibition of Phosphodiesterase Enzymes
      • 4 Stress-related Neuropeptides
      • 5 Conclusion and Future Directions
      • Acknowledgments
    • Chapter 13: Cognitive interventions for addiction medicine: Understanding the underlying neurobiological mechanisms
      • Abstract
      • 1 Introduction
      • 2 Cognitive Interventions
      • 3 Summary
      • 4 Conclusion and Future Directions
      • Acknowledgments
    • Chapter 14: Adolescent psychotherapy for addiction medicine: From brain development to neurocognitive treatment mechanisms
      • Abstract
      • 1 Overview
      • 2 Adolescent Brain Development and Addiction
      • 3 Neurocognitive Responses to Intervention
      • 4 Conclusions and Future Directions
    • Chapter 15: Cognitive neuroscience of cognitive retraining for addiction medicine: From mediating mechanisms to questions of efficacy
      • Abstract
      • 1 Introduction
      • 2 Cognitive Bias Modification
      • 3 Mechanisms of CBM
      • 4 CBM: (When) Does It Work?
      • 5 Developments in dual-process Models
      • 6 Enhancing Efficacy and Efficiency of CBM
      • 7 Conclusion and Future Directions
    • Chapter 16: Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders: From cognitive improvement to relapse prevention
      • Abstract
      • 1 Introduction
      • 2 Potential Cognitive Targets for Rehabilitation
      • 3 Cognitive Rehabilitation Therapy Methods
      • 4 Efficacy of Neurocognitive Rehabilitation in Addiction Medicine
      • 5 Methods for Presenting the Rationale of CRT to Patients with Addictions
      • 6 Principles of Cognitive Rehabilitation for Drug Addiction
      • 7 Challenges of CRT for Addiction
      • 8 Conclusions and Future Directions
      • Acknowledgments
    • Chapter 17: Noninvasive brain stimulation for addiction medicine: From monitoring to modulation
      • Abstract
      • 1 Introduction
      • 2 NIBS for Neurochemical and Neuroplasticity Assessments
      • 3 Using Repetitive NIBS as a Mechanistic and Therapeutic Tool
      • 4 NIBS and Clinical Practice in Addiction Medicine: Limitations, Open Problems, and Future Directions
      • Acknowledgments
    • Chapter 18: What the alcohol doctor ordered from the neuroscientist: Theragnostic biomarkers for personalized treatments
      • Abstract
      • 1 Introduction
      • 2 Individual Treatment Predictive Biomarkers: Theragnostics
      • 3 Alcohol-induced Dopamine Activation as a Theragnostic Biomarker
      • 4 Measures of Glutamate Activity as Theragnostic Biomarkers
      • 5 Conclusions and Future Directions
    • Chapter 19: What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses
      • Abstract
      • 1 Introduction
      • 2 Part 1: Understanding the NeuroCircuitry of Addiction and Use the Power of Brain Stimulation
      • 3 Part 2: Understanding the Neurochemical Signature of Addiction and Use this to Impact Clinical Care
      • 4 Part 3: Understanding the Role of Genetic Factors and Use this to Impact Clinical Care
      • 5 Conclusion and Future Directions
      • Acknowledgment
  • Index
  • Other volumes in Progress in Brain Research

Description

Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Methods and Interventions is the latest volume from Progress in Brain Research focusing on new trends and developments in addiction research. This established international series examines major areas of basic and clinical research within neuroscience, as well as popular emerging subfields such as addiction. This volume takes an integrated approach to review and summarize some of the most recent progress from the subfield of addiction research, with particular emphasis on potential applications in a clinical setting.

Key Features

  • Explores new trends and developments in basic and clinical research in the addiction subfield of neuroscience
  • Uses an integrated approach to review and summarize recent progress
  • Emphasizes potential applications in a clinical setting
  • Enhances the literature of neuroscience by further expanding the established international series Progress in Brain Research

Readership

Neuroscientists, psychologists, neurologists


Details

No. of pages:
488
Language:
English
Copyright:
© Elsevier 2016
Published:
Imprint:
Elsevier
eBook ISBN:
9780444637406
Hardcover ISBN:
9780444637161

Reviews

"...a notable work and an important reference for those in this field. It is also an invaluable resource for those interested in developing a better understanding of this highly complicated subject. Score: 98 - 5 Stars!" --Doody's


About the Serial Volume Editors

Hamed Ekhtiari Serial Volume Editor

Affiliations and Expertise

Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran

Martin Paulus Serial Volume Editor

Affiliations and Expertise

Laureate Institute for Brain Research, Tulsa, OK, USA